Embolx: Funding, Investors & Team (Oct 2026)
A startup medical device business in Silicon Valley called Embolx is creating microcatheters for artery embolization operations. Embolx is dedicated to significantly enhancing the management of a number of ailments, such as malignant tumors, benign prostatic hyperplasia, and uterine fibroids. The Sniper balloon occlusion microcatheter raises the bar for precision embolic administration and superior target filling by directing blood flow while safeguarding neighboring tissues that are not the target.
Embolx has raised $1.6M across 1 funding round on record, the most recent an undisclosed round of $1.6M announced in Nov 2022.
That round is in line with the $1.7M median round size for Medical Equipment Manufacturing companies tracked on FundedIQ over the last two years.
Embolx Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Embolx Funding Rounds
Embolx Founders and Leadership Team
No contact details are on record for this team yet.
Embolx Funding Compared to Other Medical Equipment Manufacturing Startups
Embolx's latest round of $1.6M is in line with the median round in Medical Equipment Manufacturing. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Embolx in Medical Equipment Manufacturing and Sunnyvale
Companies Similar to Embolx
By creating Sonic Lumen Tomography (SLTTM), a revolutionary intravascular ultrasound technique that gives…
Openwater is creating advanced imaging technologies that offer high resolution at a low cost. These…
UN&UP is an organization that helps people with unmet needs and those who are underprivileged.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform. It enables…
Among patients with mitral valve regurgitation, NeoChord, a privately held medical technology business, is…
Galen Robotics is creating a single-platform solution to assist surgeons in a variety of specialties with no…
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Embolx Funding FAQs
What does Embolx do?
A startup medical device business in Silicon Valley called Embolx is creating microcatheters for artery embolization operations. Embolx is dedicated to significantly enhancing the management of a number of ailments, such as malignant tumors, benign prostatic hyperplasia, and uterine fibroids. The Sniper balloon occlusion microcatheter raises the bar for precision embolic administration and superior target filling by directing blood flow while safeguarding neighboring tissues that are not the target.
How much funding has Embolx raised?
Embolx has raised $1.6M across 1 round on record. The most recent is an undisclosed round of $1.6M announced in Nov 2022.
When did Embolx last raise funding?
Embolx's most recent funding round on record is an undisclosed round of $1.6M, announced in Nov 2022.
Who is the CEO of Embolx?
Michael Allen is listed as CEO at Embolx.
Where is Embolx headquartered?
Embolx is based in Sunnyvale, California, United States.
How many employees does Embolx have?
Embolx is in the 11-50 employee band.
How does Embolx's funding compare to other Medical Equipment Manufacturing startups?
Embolx's latest round of $1.6M is in line with the $1.7M median round size for Medical Equipment Manufacturing companies on FundedIQ across 12 tracked companies over the last two years.
About FundedIQ's Embolx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Embolx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.